Team:St Andrews/Omega-3-synthesis

From 2012.igem.org

(Difference between revisions)
(links)
 
(43 intermediate revisions not shown)
Line 17: Line 17:
-
     <div class="container" id="content-container">
+
     <div class="container" id="content-container" style="background-image:url('https://static.igem.org/mediawiki/2012/thumb/6/60/Omega3logo2Watermark.jpg/281px-Omega3logo2Watermark.jpg');background-repeat:no-repeat;background-position:top right;background-size:35%">
<!-- Masthead
<!-- Masthead
Line 27: Line 27:
     <ul class="nav nav-pills">
     <ul class="nav nav-pills">
       <li><a href="#content-container">Introduction</a></li>
       <li><a href="#content-container">Introduction</a></li>
-
       <li><a href="#project-description">Project Description</a></li>
+
       <li><a href="#project-description">Project description</a></li>
-
       <li><a href="#synthesizing-pathway">Synthesizing the pathway</a></li>
+
       <li><a href="#Recreating-pathway">Recreating the pathway</a></li>
       <li><a href="#methods">Methods</a></li>
       <li><a href="#methods">Methods</a></li>
       <li><a href="#results">Results</a></li>
       <li><a href="#results">Results</a></li>
-
       <li><a href="#biobricks">Biobricks<sup>TM</sup></a></li>
+
       <li><a href="#biobricks">Biobricks</a></li>
       <li><a href="#references">References</a></li>
       <li><a href="#references">References</a></li>
     </ul>
     </ul>
Line 42: Line 42:
</div>
</div>
<img src="https://static.igem.org/mediawiki/2012/5/57/OmegaThreeLogo_100.png" align="left"></img>
<img src="https://static.igem.org/mediawiki/2012/5/57/OmegaThreeLogo_100.png" align="left"></img>
-
<p>ω-3 Fatty acids are an essential component of our diet and are paramount to maintaining human health. Our team is recreating this synthetic pathway in E. coli, using genes from the cyanobacteria Synechocystis and the trypanosomatid Leishmania major. Combining the DNA code for elongase and desaturase enzymes, we can convert the plain fatty acid of E. coli into highly valuable ω-3 fatty acids.</p>
 
 +
<p>ω-3 fatty acids are a key component of the human diet. Our team is recreating this synthetic pathway in <i>E. coli</i>, using genes from the cyanobacteria Synechocystis and the trypanosomatid Leishmania major. Combining the DNA code for elongase and desaturase enzymes, we are planning to convert a fatty acid with a single desaturation into highly valuable ω-3 fatty acids.</p>
 +
<br>
</section>
</section>
<section id="project-description">
<section id="project-description">
<div class="page-header">
<div class="page-header">
-
<h1>Project Description</h1>
+
<h1>Project description</h1>
</div>
</div>
Line 58: Line 59:
<div class="image-caption">
<div class="image-caption">
-
<p><center><i>Synechocystis sp.</i></center></p>
+
<p><h5>Figure 1: <em>"Synechocystis sp."</em></h5></p>
</div>
</div>
                     </div>
                     </div>
Line 67: Line 68:
                         <img src="https://static.igem.org/mediawiki/2012/5/58/Trypanosoma-cruzi.jpg" alt="" />
                         <img src="https://static.igem.org/mediawiki/2012/5/58/Trypanosoma-cruzi.jpg" alt="" />
<div class="image-caption">
<div class="image-caption">
-
<p><center><i>Trypanosome cruzi</i></center></p>
+
<p><h5>Figure 2: <em>"Trypanosome cruzi"</em></h5></p>
</div>
</div>
                     </div>
                     </div>
Line 76: Line 77:
                         <img src="https://static.igem.org/mediawiki/2012/4/48/Leishmania_major_promastigotes_edit.jpg" alt="" />
                         <img src="https://static.igem.org/mediawiki/2012/4/48/Leishmania_major_promastigotes_edit.jpg" alt="" />
<div class="image-caption">
<div class="image-caption">
-
<p><center><i>Leishmania major</i></center></p>       
+
<p><h5>Figure 3: <i>"Leishmania major"</i></h5></p>       
</div>
</div>
                     </div>
                     </div>
Line 85: Line 86:
<p></p>
<p></p>
-
       <p>Omega-3 fatty acids are an essential part of the human diet (Bender, Bender, 1999). Human beings, as all larger organisms, cannot synthesize ω-3 fatty acids, This is due to a lack of the enzyme Δ15 desaturase, which creates a double bond at the 15th carbon of a long-chain fatty acid. Certain microrganisms, such as microalgae and cyanobacteria, do contain this desaturase and can thus directly synthesize ω-3 fatty acids (Arts <i>et al</i>, 2009). ω-3 fatty acids then enter the food chain – algae are eaten by fish, and seafood is sbsequently the main source of ω-3 for humans(Tonon et al, 2002).</p>
+
 
-
<p>However, the current economic policies of overfishing are a serious contributor to marine biodestruction. As the human population is estimated to rise to 9.1 billion by 2050 (Cohen, 2003), pressure on fish stock will increase. Additionally, global warming will reduce the availability of ω-3 (Arts et al, 2009):  at higher temperatures, microalgae produce less ω-3 desaturated fatty acids. Desaturated carbon chains cause a lower melting temperature in the membrane, which the microorganism wants to avoid by synthesizing more saturated fatty acids in their membranes (Garwin, Cronan, 1980). Thus, the combination of declining fish stock and a decrease in overall ω-3 fatty acids is making the supply for human nutrition a relevant issue. </p>
+
       <p>Omega-3 fatty acids are an essential part of the human diet (Bender, Bender, 1999). Human beings, like all larger organisms, cannot synthesize ω-3 fatty acids. This is due to a lack of the enzyme Δ15 desaturase, which creates a double bond at the 15th carbon of a long-chain fatty acid. Certain micro-organisms, such as microalgae and cyanobacteria, do contain this desaturase and can thus directly synthesize ω-3 fatty acids (Arts <i>et al.</i>, 2009). ω-3 fatty acids then enter the food chain – algae are eaten by fish, and seafood is subsequently the main source of ω-3 for humans (Tonon et al., 2002).</p>
 +
<p>However, the current economic policies of overfishing are a serious contributor to marine biodestruction. As the human population is estimated to rise to 9.1 billion by 2050 (Cohen, 2003), pressure on fish stock will increase. Additionally, global warming will reduce the availability of ω-3 (Arts et al., 2009):  in response to high temperatures, microalgae produce less ω-3 desaturated fatty acids and more saturated fatty acids, as desaturated carbon chains cause a lower melting temperature in membranes (Garwin, Cronan, 1980). Thus, the combination of declining fish stock and a decrease in overall ω-3 fatty acids is making the supply for human nutrition a relevant issue. </p>
<p>Harvesting algae directly is costly and ineffective (Borowitzka, 1997). There is much potential in expressing a metabolic pathway for ω-3 fatty acid synthesis in <i>E. coli</i>, which is cheaper and more accessible. </p>
<p>Harvesting algae directly is costly and ineffective (Borowitzka, 1997). There is much potential in expressing a metabolic pathway for ω-3 fatty acid synthesis in <i>E. coli</i>, which is cheaper and more accessible. </p>
-
<section id="synthesizing-pathway">
+
<section id="Recreating-pathway">
<div class="page-header">
<div class="page-header">
-
<h1>Synthesizing the pathway</h1>
+
<h1>Recreating the pathway</h1>
</div>
</div>
Line 98: Line 100:
<div class="span6">
<div class="span6">
<img src="https://static.igem.org/mediawiki/2012/8/88/Pathway.gif" alt="" />
<img src="https://static.igem.org/mediawiki/2012/8/88/Pathway.gif" alt="" />
-
<p><i>E. coli</i> naturally synthesize poly-unsaturated fatty acids up to a carbon chain length of 18, with a single desaturation at the 9th carbon (18:1) (Marr, Ingraham, 1969). Valuable ω-3 fatty acids require 3 double bonds, and need to have a chain length between 18 and 22 carbons. The double bonds needs to start at the thrid carbon, counting from the end of the carbon chain.
+
<p><h5>Figure 4: <em>"The metabolic pathway to ω-3 fatty acids"</em></h5></p>
-
 
+
<div class="span5"><p>Figure 4 shows the elongation and desaturation enzymes necessary to convert an 18:1 fatty acid, into an poly-unsaturated fatty acid.</p>
-
<p>In order to have <E. coli</i> synthesize ω-3 fatty acids, we needed to introduce enzymes that could elongate and desaturate fatty acid substrates. As seen in the figure above, this pathway can be recreated by a number of desaturases and elongases.</p>
+
<p><em>modified from Livore et al., 2006</em></p>  
</div>
</div>
 +
</div>
 +
<div class="span6">
<div class="span6">
-
<p>The genes for Δ12, Δ15 (ω6) and Δ6 were obtained from <i>Synechocystis sp.</i>, a cyanobacterium. The trypanosomatid <i>Leishmania major</i> provided the DNA for the ELO 6 gene. Additionally, we used <i>Trypanosome cruzi</i> as a secondary source of Δ12. (cf. Fig. 2) </p>
+
<p><i>E. coli</i> naturally synthesize unsaturated fatty acids up to a carbon chain length of 18, with a single desaturation (18:1) (Marr, Ingraham, 1969). Valuable ω-3 fatty acids require a double bonds at the third carbon from the end of its carbon chain and can have >20 carbons.</p>
-
<p>However, our first successful ligations of Δ12 did not yield us with the expected 18:2 fatty acid. We hypothesized that E. coli’s inherent 18-carbon chain fatty acid might not be suited as a substrate for Δ12 – perhaps the double bond is in a different position. Therefore, we "fed" our cells with suitable 18:1, to then observe 18:2 fatty acid in the mass spec results!</p>
+
<p>In order to have <i>E. coli</i> synthesize ω-3 fatty acids, we needed to introduce enzymes that could elongate and desaturate fatty acid substrates (cf. Fig. 4).</p>
 +
<p>The genes for Δ12, Δ15 (ω6) and Δ6 were obtained from <i>Synechocystis sp.</i>, a cyanobacterium. The trypanosomatid <i>Leishmania major</i> provided the DNA for the ELO 6 gene. Additionally, we used <i>Trypanosome cruzi</i> as a secondary source of Δ12.</p>
 +
 
 +
<p>However, our first successful ligations of Δ12 did not provide us with the expected 18:2 fatty acid. We hypothesized that <i>E. coli</i>’s inherent 18-carbon chain fatty acid might not be suited as a substrate for Δ12 – the double bond is in a different position, the 11th. Therefore, we "fed" our cells with suitable 18:1, to then observe 18:2 fatty acid, and ultimately ω-3 desaturation, in the mass spec results!</p>
</div>
</div>
</div>
</div>
Line 118: Line 125:
<div class="row-fluid">
<div class="row-fluid">
<div class="span6">
<div class="span6">
-
<h2>Sequences</h2>
 
-
<p>
 
-
<p>By combining a number of genes, we were able to recreate the pathway described above (Fig. 4). The following genes were employed (please click for sequences and KEGG numbers):</p>
 
-
<p>
+
<p> The following genes were employed (please click for sequences and KEGG numbers):</p>
 +
 
<div class="btn-toolbar">
<div class="btn-toolbar">
Line 293: Line 298:
<BR>
<BR>
-
<h2>PCR</h2>
+
 
-
<p><p>These genes were extracted using PCR (Promega, GoTaq HotStart) at temperatures 48°C and 56°C. Both vectors pET-15b and pET-20b were tested for expression. The recombinant plasmids were ligated into two <i>E. coli</i> strains: BL21(DE3) and BL21(DE3)pLysS.</p></p>
+
<p>These genes were amplified through PCR (Promega, GoTaq HotStart) at temperatures 48°C and 56°C.</p>
 +
<p>The genes were initially ligated into pET-15b vector. After a number of expression attempts, some initial conclusions were reached. All experiments done on ELO6 failed. Also, Δ12 from <i>T. cruzi</i> gave overall weaker results than the same gene from <i>Synechocystis</i>. As such, latter work was only carried out on genes from <i>Synechocystis</i>.</p>
 +
<p>Then, Δ6, Δ12, and Δ15 desaturases were successfully ligated into two distinct pET-Duet vectors (vectors with two multicloning sites). One vector contained Δ12 and Δ15 desaturases, and the other was ligated only with Δ6 desaturase.</p>
 +
<p>Protein expression was clear after transformation into cell strain BL21(DE3) and induction by IPTG. However, functionality could not be established. It was hypothesized that the naturally-occuring 18:1 fatty acid in <i>E. coli</i> is the wrong substrate for the desaturases. This fatty acid has its desaturation at the 11th carbon, not at the 9th position required for a substrate. Thus, the <i>E. coli</i> were fed 18:1 (Δ9).</p>
 +
 
 +
<p>Full characterisatin and quantification of the fatty acid composition in transformed <i>E. coli</i> was performed by fatty acid conversion to the corresponding fatty acid methyl esters (FAMEs) followed by GC-MS analysis. In this way, lipid profiles of membrane assays and lipid extracts from cells were obtained.</p>
 +
 
 +
<p>After characterization, we ligated each of our desaturases into the submission vector pSB1C3.</p>
</div>
</div>
 +
<div class="span6 well">
<div class="span6 well">
     <ul class="thumbnails">
     <ul class="thumbnails">
 +
     <img src="https://static.igem.org/mediawiki/2012/6/61/PCR_of_genes.png" alt="">
     <img src="https://static.igem.org/mediawiki/2012/6/61/PCR_of_genes.png" alt="">
<p><h5>Fig. 5: <em>"UV photograph of PCR results"</em></h5></p>
<p><h5>Fig. 5: <em>"UV photograph of PCR results"</em></h5></p>
Line 416: Line 430:
</div>
</div>
-
<p>When using the pET-duet vector, we needed additionally primers for the alternative restriction sites and His-tags. For Δ6 and Δ12, we cut with HindIII and EcoRI; NdeI and XhoI were used for Δ15 and ELO6.</p>
+
<p>When using the pET-duet vector, we needed additional primers for the alternative restriction sites and His-tags. For Δ6 and Δ12, we cut with HindIII and EcoRI; NdeI and XhoI were used for Δ15 and ELO6.</p>
<div class="btn-toolbar">
<div class="btn-toolbar">
Line 513: Line 527:
</div>
</div>
-
<p>After a number of expression attempts, some initial conclusions were reached. All experiments done on ELO6 failed. Also, Δ12 from <i>T. cruzi</i> gave overall weaker results than the same gene from <i>Synechocystis</i>.  As such, latter work was only carried out on genes from <i>Synechocystis</i>.</p>
 
-
 
-
<p> Δ6,  Δ12, and Δ15 was successfully expressed in pET-15b and transformed into cell strains BL21(DE3) and BL21(DE3)PlysS. However, functionality could not be established. It was hypothesized that the naturally-occuring 18:1 fatty acid in <i>E. coli</i> is the wrong substrate for the desaturases. This fatty acid has its desaturation at the 11th carbon. Thus, the <i>E. coli</i> were manually fed 18:1 (Δ9).</p>
 
-
 
-
<p>Additionally, a pET-duet vector expressing Δ12 and Δ15 was used to start assembling the metabolic pathway. Due to time constraints, no duet vector BioBrick<sup>TM</sup> was submitted.</p>
 
Line 531: Line 540:
<strong>Mass Spectrometry</strong>
<strong>Mass Spectrometry</strong>
<p>Lipids were extracted from transformed <i>E. coli</i> using the Blight/Dyer method. (Please refer to the <a href="https://2012.igem.org/Team:St_Andrews/Lab-book">Lipid extraction lab book entry</a> for further detail.)</p>  
<p>Lipids were extracted from transformed <i>E. coli</i> using the Blight/Dyer method. (Please refer to the <a href="https://2012.igem.org/Team:St_Andrews/Lab-book">Lipid extraction lab book entry</a> for further detail.)</p>  
-
<p>We then analyzed the the fatty acid content of the transformed cells to determine whether it differed from the previously analyzed background lipid composition. This was done using mass spectrometry.</p>
+
<p>The fatty acid content of the transformed cells was measured to determine whether it differed from the previously analyzed background lipid composition. This was done using mass spectrometry.</p>
</div>
</div>
<div class="span2">
<div class="span2">
<strong>Bradford protein assay</strong>
<strong>Bradford protein assay</strong>
-
<p>A Bradford protein assay was carried out to asses protein concentration (Bradford, 1976).</p>  
+
<p>A Bradford protein assay was carried out to assess protein concentration (Bradford, 1976).</p>  
</div>
</div>
Line 553: Line 562:
</div>
</div>
 +
<p>The fatty acids were released by base hydrolysis followed by organic extraction, the resulting fatty acids were derivatised with diazomethane to the corresponding fatty acid methyl esters (FAMEs), together with fatty acid standards. The samples were analysed by GC-MS and the retention times and fragmentation patterns, compared with FAME standards. The results are shown in Charts 3,4 and 5.<p>
 +
<p>By combining a number of genes, we were able to partially recreate the pathway described above (Fig. 4).<p>
 +
<p>Due to time constraints, we were unable to submit a BioBrick containing the sequence of all of the necessary genes for the ω-3 biosynthetic pathway. However, we were able to express and characterise Δ12, Δ15 and Δ6 desaturases, the first three enzymes involved in ω-3 biosynthesis. As shown in charts 2, 3 and 4, the presence of alpha-linoleic acid (18:3<sup>Δ9,12,15</sup>), an omega-3 fatty acid, can be observed in <i>E. coli</i>. This does not occur naturally in their bacterial membrane.</p>
-
<h2>Bradford protein assay</h2>
 
-
 
-
<div class="row-fluid">
 
-
<div class="span6 well">
 
-
    <ul class="thumbnails">
 
-
    <img src="http://a0.twimg.com/sticky/default_profile_images/default_profile_0_reasonably_small.png" alt="">
 
-
<p><h5>Chart 1: <em>"Bradford protein assay"</em></h5></p>
 
-
<p>This chart shows the results of a Bradford protein assay. It was carried out on the following ligated plasmids transformed into BL21: Δ12 in pET-15b (in 2 colonies), Δ12 in pLYS, Δ12 in pET-duet (in 2 colonies), Δ6 in pET-duet, Δ12/Δ15 in pET-duet (in 2 colonies). </p>
 
-
  </ul>
 
-
</div>
 
-
 
-
 
-
<div class="span4">
 
-
<p>The Bradford protein assay discuss results</p>
 
-
</div>
 
-
</div>
 
Line 581: Line 577:
     <img src="https://static.igem.org/mediawiki/2012/4/4e/Fame_analysis.png" alt="">
     <img src="https://static.igem.org/mediawiki/2012/4/4e/Fame_analysis.png" alt="">
     <p><h5>Chart 2: <em>"Fatty acid methyl ester analysis"</em></h5></p>
     <p><h5>Chart 2: <em>"Fatty acid methyl ester analysis"</em></h5></p>
-
     <p>C18:3 refers to an 18 carbon backbone with 3 double bonds. C18:2 and C18:1 would have 2 double bonds and 1 respectively. The upper portion of this figure shows the peaks that would be expected for the various fatty acid methyl esters.The lower 4 panels show mass spec fingerprints that are indicative of our fatty acids of interest.</p>
+
     <p>C18:3 refers to an 18 carbon backbone with 3 double bonds. C18:2 and C18:1 would have 2 double bonds and 1 respectively. The upper portion of this figure shows the peaks generated by the standard expected fatty acid methyl esters.The lower 4 panels show mass spec fingerprints that are indicative of our fatty acids of interest.</p>
     </a>
     </a>
     </li>
     </li>
Line 598: Line 594:
     <img src="https://static.igem.org/mediawiki/2012/c/c6/Slide2.tiff" alt="">
     <img src="https://static.igem.org/mediawiki/2012/c/c6/Slide2.tiff" alt="">
     <p><h5>Chart 3: <em>"Lipid extraction analysis"</em></h5></p>
     <p><h5>Chart 3: <em>"Lipid extraction analysis"</em></h5></p>
-
     <p>All of the cellular lipids were extracted and their fatty acid methyl esters produced. These were analysed by mass spec. In the control cells no C18:2 is present. When Δ6 is expressed, a peak indicative of C18:2 is present. However, the primary fatty acid is still C18:1 - with the bouble bond present at position 9. With the expression of Δ12 and the addition of exogenous C18:1(3) we get great abundance of C18:2 and negligible abundance of C18:1 indicating that the C18:1 is being processed successfully. The lowest graph shows that Δ12 expressed with Δ15 acts in a complementary fashion and C18:3 - Omega 3 - is produced. </p>
+
     <p>All of the cellular lipids were extracted and their fatty acid methyl esters produced. These were analysed by mass spec. In the control cells no C18:2 is present. When Δ6 is expressed, a peak indicative of C18:2 is present. However, the primary fatty acid is still C18:1 - with the bouble bond present at position 9. With the expression of Δ12 and the addition of exogenous C18:1(Δ9) we get great abundance of C18:2 and negligible abundance of C18:1 indicating that the C18:1 is being processed successfully. The lowest graph shows that Δ12 expressed with Δ15 acts in a complementary fashion and the expected C18:3 - an Omega 3 - is produced. </p>
     </a>
     </a>
     </li>
     </li>
Line 632: Line 628:
</div>
</div>
 +
<h2>Bradford protein assay</h2>
-
<h2>Sequencing results</h2>
+
<div class="row-fluid">
-
<dl class="dl-horizontal">
+
<div class="span6 well">
-
<dt>16/7/12 Δ15</dt>
+
    <ul class="thumbnails">
-
        <dd><p><ul>Δ15 and  Δ6 desaturases from <i>Synechocystis</i> in pET-15b were sent off for sequencing. Once again, the results were discouraging even though protein and lipid analysis showed the opposite. BLAST showed that the gene found in both samples corresponded to a <i>T. brucei</i> HMG-CoA reductase which we thought we had cut out from the plasmid. We thus performed a PCR, using the vectors sent off for sequencing as a template.</ul></p>
+
    <img src="https://static.igem.org/mediawiki/2012/b/bd/Bradford_samples.png" alt="">
 +
<p><h5>Chart 5: <em>"Bradford protein assay"</em></h5></p>
 +
<p>This chart shows the standard results of a Bradford protein assay. Measuring the absorbance at 595nm for set samples, a standard curve was calculated with the equation of y = 0.0006x + 0.0426.</p>
 +
  </ul>
 +
</div>
-
        <p><ul><a data-toggle="modal" href="#modal7" class="btn btn-primary btn-mini"><font color="white">Sequence</font></a>
 
-
<div class="modal hide" id="modal7">
 
-
  <div class="modal-header">
 
-
    <button type="button" class="close" data-dismiss="modal">×</button>
 
-
    <h3>Δ15 Syn. in pET-15b</h3>
 
-
  </div>
 
-
  <div class="modal-body">
 
-
    <p><span style="text-transform: uppercase;">atATACCAtggGcAgCAGccaTcnnCATcaTCAtnncAGCagCGGCCTggtgCCGCGCGGCAGCCATATGCTTCgtagga
 
-
cTCTCTCatgtgCTtgtGGGACAGGCAAAACGGGttgGGGCGCAAtgaGCAATGCCgagCTTGTTaAAGCcgtAAGCAgt
 
-
cGTCAAttAACCTTTTATGGGTTAGAGCacgCTCTGgagCCCGACTACCAGCGCGCTATCGcTgtGCGTCGtgAGGTGgt
 
-
gtCCGACTAtgtgGCATCCTCCCAAAgTGCggaGGTGAAGAGGAAAAGCTTGGAGCGTATACCATTTGAAAACTACGAAT
 
-
GGGATCGAGTGGTTGGTCAGAACTGTGAAAATATTGTGGGTTACGTTCCTATTCCTCTTGGTATGGCTGGGCCAATAATA
 
-
ATGGATGGCTGTGAATACCCCATTCCCATGGCCACGACAGAAGGTGCCCTggtTGCCAGCACACATCGAGGCGCACGAGC
 
-
TATATCCCAAAGTGGGGGCTGTAAGACACTGATCTTGGGCGAGGGCATGTCACGTGCTCCAGTAGTGGAGGTTGAGTCTT
 
-
TGGAAGAGGCGGGAAggcttCATAATTTTTGTGTagaAAAtttcaCTGAAATCAAAGCAGCTTTCGAGagaCGACGCGAT
 
-
TTGGGAattGCAGTCGCTCAAGTGCGTCATCATCGGTCnnnannCCTATATTCggTTCCGCGCGAccaCCGGagatGCga
 
-
tg
 
-
</p>
 
-
  </div>
 
-
  <div class="modal-footer">
 
-
    <a href="#" class="btn" data-dismiss="modal">Close</a>
 
-
    </div>
 
-
</div></ul>
 
-
</ul></p></dd>
 
-
<dt>16/7/12 Δ6</dt> 
+
<div class="span4 well">
-
        <dd><p><ul><a data-toggle="modal" href="#modal8" class="btn btn-primary btn-mini"><font color="white">Sequence</font></a>
+
<ul class="thumbnails">
-
<div class="modal hide" id="modal8">
+
     <img src="https://static.igem.org/mediawiki/2012/1/18/Protein_conc._table.png" alt="">
-
  <div class="modal-header">
+
<p><h5>Table 1: <em>"Bradford protein assay"</em></h5></p>
-
     <button type="button" class="close" data-dismiss="modal">×</button>
+
<p>Using the standard curve shown in chart 5, the protein concentrations of a number of transformed plasmids was calculated.</p>
-
    <h3>Δ6 Syn. in pET-15b</h3>
+
  </ul>
-
  </div>
+
-
  <div class="modal-body">
+
-
    <p><span style="text-transform: uppercase;">AnTTCCCCcTctaGaaTaTTTTTGTTtACTTtAAGaAGGAGATATACCATGGGCAGCAGCCATcncTcAtcaTCATCACA
+
-
GCAGCGGCCTGGTGCCGCGCGGCAGCCATATGCTTCGTAGGACTCTCTCATgtGCTTGTGGGACAGGCAAAACGGGTTGG
+
-
GGCGCAATGAGCAATGCCGaGCTtgTTAAAGCCGTAAGCAGTCGTCAATTAACCTTTTATGGGTTAGAGCAGGCTCTGGA
+
-
GCCCGACTACCAGCGCGCTATCGCTGTGCGTCGTGAGGTGGTGTCCGACTATGTGGCATCCTCCCAAAGTGCGGAGGTGA
+
-
AGAGGAAAAGCTTGGAGCGTATACCATTTGAAAACTACGAATGGGATCGAGTGGTTGGTCAGAACTGTGAAAATATTGTG
+
-
GGTTACGTTCCTATTCCTCTTGGTATGGCTGGGCCAATAATAATGGATGGCTGTGAATACCCCATTCCCATGGCCACGAC
+
-
AGAAGGTGCCCTGGTTGCCAGCACACATCGAGGCGCACGAGCTATATCCCAAAGTGGGGGCTGTAAGACACTGATCTTGG
+
-
GCGAGGGCATGTCACGTGCTCCAGTAGTGGAGGTTGAGTCTTTGGAAGAGGCGGGAAGGCTTCATAATTTTTGTGTAGAA
+
-
AATTTCACTGAAATCAAAGCAGCTTTCGAGAGCACGACGCGATTTGGGAAGTTGCAGTCGCTCAAGTGCGTCATCATCGG
+
-
TCGCAnAGCCTATATTCGGTTCCGCGCGACCACCGGAGATGCGATGGGGATGAACATGATAACCAAAGGTGTCGACAAGG
+
-
CATTGGAGTTAAtanAGCAnAACTTTCCGTCGATGAAGGTTATTGCGTTGTCGGGGAACTACTGCACTGanaagAAACcC
+
-
TCCGCAGTGAACTGGATTGaggggaaGAGGAAnAAaCTGTcnnttgCCgaagGCGCTcgtaaaggggCgaAGt
+
-
</p>
+
-
  </div>
+
-
  <div class="modal-footer">
+
-
    <a href="#" class="btn" data-dismiss="modal">Close</a>
+
-
    </div>
+
-
</div></ul>
+
-
</ul></p></dd>
+
-
<dt>29/6/12 ELO6</dt> 
+
</div>
-
        <dd><p><ul>After showing successful insertion of <i>L. major</i> Δ6 elongase in pET-15b, the sample was sent off for sequencing. Unfortunately, the gene sequenced was not the Δ6 elongase we were hoping to find, but a <i>T. brucei</i> mevalonate kinase, which was previously inserted in the pET-15b vectors we had been using. Thus, we digested some fresh pET-15b to be used in the future.</ul></p>
+
</div>
-
 
+
-
        <p><ul><a data-toggle="modal" href="#modal6" class="btn btn-primary btn-mini"><font color="white">Sequence</font></a>
+
-
<div class="modal hide" id="modal6">
+
-
  <div class="modal-header">
+
-
    <button type="button" class="close" data-dismiss="modal">×</button>
+
-
    <h3>ELO6 in pET-15b</h3>
+
-
  </div>
+
-
  <div class="modal-body">
+
-
    <p><span style="text-transform: uppercase;">GnanTTTGTTtAcTttaagaaggagaTATACCATGGGcAGCAGCCATcatCATcatcaTCACAGCAGCGGCCTggtGCCG
+
-
CGCGGCagCCATATGGTCGTGGCATCGtgTCCGGGAAAAGTGCTGATTCTTGGTGGTTAcCTAATAGttGAGGAGCCAAA
+
-
TGTTGGTATTTCCGTAGGAACAACCGCGCGCTTCGTGACACGTGTGGCGTCgtgGAAAAAATGCTCTGATGGAAAGTGTC
+
-
GAGTGCACATCGTCTCGTCACAGTTCAACAAggaGTTTACGTTTGAATGCGCGGCTGAAGAGGACAGTGATTCCACTATC
+
-
AAGATTGTGCAATTAGAGGGTGCACCATCGCCGTTTCTCTTCTACGGTATTTTGTACTCGGTTGCCGGCGCTCTATTATT
+
-
TGGTGGTGATATTTTTCGTGATGTTACCCTAGAGTTGTTGGCGGATAACGATTTCTACAGCCAAAGGAATTATTTGGAGT
+
-
CCCAAGGCAAGCCGGTGACCGCAGCCAACCTGCGGCTCATCCCCCGTTATACGCCCCTCTTGGGGGAGGTTTCCAAAACT
+
-
GGTCTAGGATCTTCAGCGGCAATGACCACTAGTGTCGTAGCGTGCCTGCTCCAACTTTTTGTTTTTGATTCGAAGAAAAA
+
-
CAATGCCACTGAGTCCGTGGAGAGGGCACCGGAGCTACCTCTACGTTTGGAGGATGTAACAGAGTTCATTCATCGTATTA
+
-
GTCAGGTTGCCCACTGCGTAGCACAGGGAAAAGTGgGGAGCGGGTTTGATGTCTACACGGCCACGTTCGGGACGTGTGTG
+
-
TACCGACGGTTCTCCGCACGCGTGCTGGAnAAGCTCGTAAAGGgtAATGAACCTCCGAAGCGCGTCGCTATTCCTCTTTT
+
-
ACGTGAGTGTGTCGAGACGGATGAAGTGTGgGTTCAGAGGATACcCTtccGGCTTCCTACCGGGTTGCAGCTTCTTTTAG
+
-
GGGATGTACACAAGGGAGgAacaGAAAcACCTGGCATGGTGTcgaAGGTCATGTCatgnnagnggTCGGTGACCacGGAC
+
-
CCcAACAGnttgnggnnnngantTcCCATgnntAAT
+
-
</p>
+
-
  </div>
+
-
  <div class="modal-footer">
+
-
    <a href="#" class="btn" data-dismiss="modal">Close</a>
+
-
    </div>
+
-
</div></ul>
+
-
</ul></p></dd>
+
-
 
+
-
        <dt>23/7/12 Δ12</dt> 
+
-
        <dd><p><ul>15b forward gave 0 nucleotides</ul></p>
+
-
            <p><ul>15b reverse gave 0 nucleotides</ul></p>
+
-
            <p><ul>20b forward gave a 41 nucleotide result.</ul></p>
+
-
            <ul><div class="btn-group">
 
-
            <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#">Sequence<span class="caret"></span>
 
-
            </a>
 
-
              <ul class="dropdown-menu">
 
-
                  <div class="span3"><font size="1">gCGnCctGntGCCgCGCGGCnnnnnnnnnnnnnnnnnngac</font></div>
 
-
              </ul>
 
-
            </div></ul>
 
-
           
 
-
            <p><ul>A BLAST search showed this to be compatible with <i>Crocosphaera watsonii</i> (genome shotgun sequence, 21%), a diazotrophic cyanobacteria.</ul></p>
 
-
            <p><ul>20b reverse gave 0 nucleotides</ul></p>
 
-
            </dd>
 
-
      </dl> 
 
</section>
</section>
Line 746: Line 656:
<section id="biobricks">
<section id="biobricks">
<div class="page-header">
<div class="page-header">
-
<h1>Biobricks<sup>TM</sup></h1>
+
<h1>Biobricks</h1>
</div>
</div>
-
<p><span class="label label-warning">TODO</span></p>
+
<p>We have submitted 3 BioBricks involved in the ω-3 biosynthetic pathway to the Registry of Standard Parts:</p>
 +
<table class="table table-striped">
 +
    <thead>
 +
        <tr>
 +
            <th>Biobrick</th>
 +
            <th>Short name</th>
 +
            <th>Description</th>
 +
            <th>Length</th>
 +
        </tr>
 +
    </thead>
 +
    <tbody>
 +
        <tr>
 +
            <td><a href="http://partsregistry.org/Part:BBa_K925000">BBa_K925000</a></td>
 +
            <td>Delta-12 desaturase</td>
 +
            <td>Desaturase introducing a double bond at the Δ-12 site in the hydrocarbon chain of oleic acid (18:1, Δ9) to give linoleic acid (18:2 Δ9,12)</td>
 +
            <td>1056</td>
 +
        </tr>
 +
        <tr>
 +
            <td><a href="http://partsregistry.org/Part:BBa_K925001">BBa_K925001</a></td>
 +
            <td>Delta-15 desaturase</td>
 +
            <td>Desaturase introducing a double bond at the Δ-15 site in the hydrocarbon chain of linoleic acid (18:2 ; Δ9,12) for its convertion into alpha-linoleic acid (18:3 ; Δ9,12,15), an ω -3 PUFA</td>
 +
            <td>1080</td>
 +
        </tr>
 +
        <tr>
 +
            <td><a href="http://partsregistry.org/Part:BBa_K925003">BBa_K925003</a></td>
 +
            <td>Delta-6 desaturase</td>
 +
            <td>Desaturase introducing a double bond at the Δ-12 site in the hydrocarbon chain of oleic acid (18:1, Δ9) to give linoleic acid (18:2 Δ9,12)</td>
 +
            <td>1080</td>
 +
        </tr>
 +
    </tbody>
 +
</table>
</section>
</section>
Line 757: Line 697:
</div>
</div>
-
<p>ARTS, <i>et al</i>, 2009. Lipids in Aquatic Ecosystems. New York. Springer.</p>
+
<p>Arts, <i>et al.</i>, 2009. Lipids in Aquatic Ecosystems. New York. Springer.</p>
-
<p>BENDER D. A. and BENDER, A. E, 1999. Benders' dictionary of nutrition and food technology. Cambridge: CRC Press.</p>
+
<p>Bender D. A. and Bender, A. E, 1999. Benders' dictionary of nutrition and food technology. Cambridge: CRC Press.</p>
-
<p>BRADFORD, M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 7;72:248-54.</p>
+
<p>Bradford, M., 1976. <a href="http://www.ncbi.nlm.nih.gov/pubmed/942051">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.</a> Anal Biochem, 7;72:248-54.</p>
-
<p>COHEN, J., 2003. Human Population: The Next Half Century. Science, New Series, Vol. 302, No. 5648. Pp. 1172-1175.</p>  
+
<p>Cohen, J., 2003. <a href="http://www.sciencemag.org/content/302/5648/1172.abstract">Human Population: The Next Half Century.</a> Science, New Series, Vol. 302, No. 5648. Pp. 1172-1175.</p>  
-
<p>GARWIN J. L. and CRONAN J. E. Jr, 1980. Thermal modulation of fatty acid synthesis in <i>Escherichia coli</i> does not involve de novo enzyme synthesis. J Bacteriol, 141(3): 1457–1459.</p>
+
<p>Garwin J. L. and Cronan J. E. Jr, 1980. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC293857/">Thermal modulation of fatty acid synthesis in <i>Escherichia coli</i> does not involve de novo enzyme synthesis.</a> J Bacteriol, 141(3): 1457–1459.</p>
-
<p>LIVORE V., TRIPODI K., UTARRO A., 2007. Elongation of polyunsaturated fatty acids in trypanosomatids. FEBS Journal, 274: 264–274.</p>
+
<p>Livore V., Tripodi K., Utarro A., 2007. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17222186">Elongation of polyunsaturated fatty acids in trypanosomatids.</a> FEBS Journal, 274: 264–274.</p>
-
<p>MARR A., INGRAHAM J., 1969.  Effect of temperature on the composition of fatty acids in <i>Escherichia coli</i>. J. Bactiol. 84(6). Pp.  1260–1267.</p>
+
<p>Marr A., Ingraham J., 1969.  <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC278056/">Effect of temperature on the composition of fatty acids in <i>Escherichia coli</i>.</a> J. Bactiol. 84(6). Pp.  1260–1267.</p>
-
<p>TONON T., <i>et al</i>, 2002. Long chain polyunsaturated fatty acid production and partitioning to triacylglycerols in four microalgae. Phytochemistry, Vol 61 Iss 1. Pgs 15-24.</p>
+
<p>Tonon T., <i>et al.</i>, 2002. <a href="http://www.sciencedirect.com/science/article/pii/S0031942202002017">Long chain polyunsaturated fatty acid production and partitioning to triacylglycerols in four microalgae.</a> Phytochemistry, Vol 61 Iss 1. Pgs 15-24.</p>
</section>
</section>

Latest revision as of 23:15, 26 September 2012

Omega-3 fatty acid synthesis

ω-3 fatty acids are a key component of the human diet. Our team is recreating this synthetic pathway in E. coli, using genes from the cyanobacteria Synechocystis and the trypanosomatid Leishmania major. Combining the DNA code for elongase and desaturase enzymes, we are planning to convert a fatty acid with a single desaturation into highly valuable ω-3 fatty acids.


  • Figure 1: "Synechocystis sp."

  • Figure 2: "Trypanosome cruzi"

  • Figure 3: "Leishmania major"

Omega-3 fatty acids are an essential part of the human diet (Bender, Bender, 1999). Human beings, like all larger organisms, cannot synthesize ω-3 fatty acids. This is due to a lack of the enzyme Δ15 desaturase, which creates a double bond at the 15th carbon of a long-chain fatty acid. Certain micro-organisms, such as microalgae and cyanobacteria, do contain this desaturase and can thus directly synthesize ω-3 fatty acids (Arts et al., 2009). ω-3 fatty acids then enter the food chain – algae are eaten by fish, and seafood is subsequently the main source of ω-3 for humans (Tonon et al., 2002).

However, the current economic policies of overfishing are a serious contributor to marine biodestruction. As the human population is estimated to rise to 9.1 billion by 2050 (Cohen, 2003), pressure on fish stock will increase. Additionally, global warming will reduce the availability of ω-3 (Arts et al., 2009): in response to high temperatures, microalgae produce less ω-3 desaturated fatty acids and more saturated fatty acids, as desaturated carbon chains cause a lower melting temperature in membranes (Garwin, Cronan, 1980). Thus, the combination of declining fish stock and a decrease in overall ω-3 fatty acids is making the supply for human nutrition a relevant issue.

Harvesting algae directly is costly and ineffective (Borowitzka, 1997). There is much potential in expressing a metabolic pathway for ω-3 fatty acid synthesis in E. coli, which is cheaper and more accessible.

Figure 4: "The metabolic pathway to ω-3 fatty acids"

Figure 4 shows the elongation and desaturation enzymes necessary to convert an 18:1 fatty acid, into an poly-unsaturated fatty acid.

modified from Livore et al., 2006

E. coli naturally synthesize unsaturated fatty acids up to a carbon chain length of 18, with a single desaturation (18:1) (Marr, Ingraham, 1969). Valuable ω-3 fatty acids require a double bonds at the third carbon from the end of its carbon chain and can have >20 carbons.

In order to have E. coli synthesize ω-3 fatty acids, we needed to introduce enzymes that could elongate and desaturate fatty acid substrates (cf. Fig. 4).

The genes for Δ12, Δ15 (ω6) and Δ6 were obtained from Synechocystis sp., a cyanobacterium. The trypanosomatid Leishmania major provided the DNA for the ELO 6 gene. Additionally, we used Trypanosome cruzi as a secondary source of Δ12.

However, our first successful ligations of Δ12 did not provide us with the expected 18:2 fatty acid. We hypothesized that E. coli’s inherent 18-carbon chain fatty acid might not be suited as a substrate for Δ12 – the double bond is in a different position, the 11th. Therefore, we "fed" our cells with suitable 18:1, to then observe 18:2 fatty acid, and ultimately ω-3 desaturation, in the mass spec results!

The following genes were employed (please click for sequences and KEGG numbers):

Δ6 Synechocystis Δ12 Synechocystis Δ15 Synechocystis ELO 6 L. major Δ12 T. Cruzi

These genes were amplified through PCR (Promega, GoTaq HotStart) at temperatures 48°C and 56°C.

The genes were initially ligated into pET-15b vector. After a number of expression attempts, some initial conclusions were reached. All experiments done on ELO6 failed. Also, Δ12 from T. cruzi gave overall weaker results than the same gene from Synechocystis. As such, latter work was only carried out on genes from Synechocystis.

Then, Δ6, Δ12, and Δ15 desaturases were successfully ligated into two distinct pET-Duet vectors (vectors with two multicloning sites). One vector contained Δ12 and Δ15 desaturases, and the other was ligated only with Δ6 desaturase.

Protein expression was clear after transformation into cell strain BL21(DE3) and induction by IPTG. However, functionality could not be established. It was hypothesized that the naturally-occuring 18:1 fatty acid in E. coli is the wrong substrate for the desaturases. This fatty acid has its desaturation at the 11th carbon, not at the 9th position required for a substrate. Thus, the E. coli were fed 18:1 (Δ9).

Full characterisatin and quantification of the fatty acid composition in transformed E. coli was performed by fatty acid conversion to the corresponding fatty acid methyl esters (FAMEs) followed by GC-MS analysis. In this way, lipid profiles of membrane assays and lipid extracts from cells were obtained.

After characterization, we ligated each of our desaturases into the submission vector pSB1C3.

    Fig. 5: "UV photograph of PCR results"

    The figure shows the results of a PCR extraction of our genes of choice, done with GoTaq HotStart PCR kit at 2 different annealing temperatures: Δ12 (48°C) - Δ12 (56°C) - Δ15 (48°C) - Δ15 (56°C) - Δ6 (48°C) - Δ6 (56°C).

Primers

All primers are notated 5' to 3'. Initially, we worked with NdeI and XhoI as the restriction sites.

Δ12 T. Cruzi forward
Δ12 T. Cruzi reverse
Δ12 Synechocystis forward
Δ12 Synechocystis reverse
Δ15 Synechocystis forward
Δ15 Synechocystis reverse
Δ6 Synechocystis forward
Δ6 Synechocystis reverse
ELO6 L. major forward
ELO6 L. major reverse

When using the pET-duet vector, we needed additional primers for the alternative restriction sites and His-tags. For Δ6 and Δ12, we cut with HindIII and EcoRI; NdeI and XhoI were used for Δ15 and ELO6.

ELO6 L. major forward
Δ15 Synechocystis sp. forward
Δ6 Synechocystis sp. forward
Δ6 Synechocystis sp. reverse
Δ12 Synechocystis sp. forward
Δ12 Synechocystis sp. reverse

For the submission vector, we once again required new primers, using restriction sites EcoRI and PstI. For Δ6 and Δ12 forward, we used the primers from the duet vector (see above).

Δ6 Synechocystis reverse
Δ15 Synechocystis forward
Δ15 and Δ12 Synechocystis reverse

Analysis

Lipid Analysis

Lipids were extracted from transformed E. coli using the Blight/Dyer method. (Please refer to the Lipid extraction lab book entry for further detail.)

Mass Spectrometry

Lipids were extracted from transformed E. coli using the Blight/Dyer method. (Please refer to the Lipid extraction lab book entry for further detail.)

The fatty acid content of the transformed cells was measured to determine whether it differed from the previously analyzed background lipid composition. This was done using mass spectrometry.

Bradford protein assay

A Bradford protein assay was carried out to assess protein concentration (Bradford, 1976).

Sequencing

We sent off samples to GATC for sequencing.

The fatty acids were released by base hydrolysis followed by organic extraction, the resulting fatty acids were derivatised with diazomethane to the corresponding fatty acid methyl esters (FAMEs), together with fatty acid standards. The samples were analysed by GC-MS and the retention times and fragmentation patterns, compared with FAME standards. The results are shown in Charts 3,4 and 5.

By combining a number of genes, we were able to partially recreate the pathway described above (Fig. 4).

Due to time constraints, we were unable to submit a BioBrick containing the sequence of all of the necessary genes for the ω-3 biosynthetic pathway. However, we were able to express and characterise Δ12, Δ15 and Δ6 desaturases, the first three enzymes involved in ω-3 biosynthesis. As shown in charts 2, 3 and 4, the presence of alpha-linoleic acid (18:3Δ9,12,15), an omega-3 fatty acid, can be observed in E. coli. This does not occur naturally in their bacterial membrane.

Mass Spectrometry

Bradford protein assay

    Chart 5: "Bradford protein assay"

    This chart shows the standard results of a Bradford protein assay. Measuring the absorbance at 595nm for set samples, a standard curve was calculated with the equation of y = 0.0006x + 0.0426.

    Table 1: "Bradford protein assay"

    Using the standard curve shown in chart 5, the protein concentrations of a number of transformed plasmids was calculated.

We have submitted 3 BioBricks involved in the ω-3 biosynthetic pathway to the Registry of Standard Parts:

Biobrick Short name Description Length
BBa_K925000 Delta-12 desaturase Desaturase introducing a double bond at the Δ-12 site in the hydrocarbon chain of oleic acid (18:1, Δ9) to give linoleic acid (18:2 Δ9,12) 1056
BBa_K925001 Delta-15 desaturase Desaturase introducing a double bond at the Δ-15 site in the hydrocarbon chain of linoleic acid (18:2 ; Δ9,12) for its convertion into alpha-linoleic acid (18:3 ; Δ9,12,15), an ω -3 PUFA 1080
BBa_K925003 Delta-6 desaturase Desaturase introducing a double bond at the Δ-12 site in the hydrocarbon chain of oleic acid (18:1, Δ9) to give linoleic acid (18:2 Δ9,12) 1080

Arts, et al., 2009. Lipids in Aquatic Ecosystems. New York. Springer.

Bender D. A. and Bender, A. E, 1999. Benders' dictionary of nutrition and food technology. Cambridge: CRC Press.

Bradford, M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 7;72:248-54.

Cohen, J., 2003. Human Population: The Next Half Century. Science, New Series, Vol. 302, No. 5648. Pp. 1172-1175.

Garwin J. L. and Cronan J. E. Jr, 1980. Thermal modulation of fatty acid synthesis in Escherichia coli does not involve de novo enzyme synthesis. J Bacteriol, 141(3): 1457–1459.

Livore V., Tripodi K., Utarro A., 2007. Elongation of polyunsaturated fatty acids in trypanosomatids. FEBS Journal, 274: 264–274.

Marr A., Ingraham J., 1969. Effect of temperature on the composition of fatty acids in Escherichia coli. J. Bactiol. 84(6). Pp. 1260–1267.

Tonon T., et al., 2002. Long chain polyunsaturated fatty acid production and partitioning to triacylglycerols in four microalgae. Phytochemistry, Vol 61 Iss 1. Pgs 15-24.

Back to top

University of St Andrews, 2012.

Contact us: igem2012@st-andrews.ac.uk, Twitter, Facebook

This iGEM team has been funded by the MSD Scottish Life Sciences Fund. The opinions expressed by this iGEM team are those of the team members and do not necessarily represent those of Merck Sharp & Dohme Limited, nor its Affiliates.